Trem-1 and Ultraviolet Radiation-induced Immune Suppression
United States70 participantsStarted 2022-03-21
Plain-language summary
The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Inclusion Criteria
* Patient age 18-35
* Patient able to understand requirements of the study and risks involved
* Patient able to sign a consent form
Exclusion Criteria:
* Patients Fitzpatrick IV-VI
* A recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post inflammatory hyperpigmentation
* Patients with eczema, psoriasis, and contact dermatitis
* A known history of photosensitivity disorders
* A known history of melanoma or non-melanoma skin cancers
* Those planning on going to the tanning parlors
* Using any of the photosensitizing medication
* A woman who is lactating, pregnant, or planning to become pregnant
* Patient planning on exposing the irradiated or control areas to the sun
* Patients with organ transplantation, an immunodeficiency disorder or the use of an immunosuppressive drug